Authors
Loading...
Reduced desmoglein-2/desmocollin-2 in explanted ARVD/C hearts may aid mechanistic insight; leaves open diagnostic or therapeutic utility pending prospective validation.
Key points are not available for this paper at this time.
Vite et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: